Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ TIMOLOL 0.5% SOLUTION Resolved 2019-09-10 2020-12-22 93445
SANDOZ TIMOLOL 0.5% SOLUTION Resolved 2022-10-19 2022-11-03 172199
SANDOZ TIMOLOL 0.5% SOLUTION Resolved 2025-10-20 2026-01-08 269910
SANDOZ TIMOLOL 0.5% SOLUTION Resolved 2022-12-28 2023-03-28 179527
SANDOZ TIMOLOL 0.5% SOLUTION Resolved 2025-07-14 2026-01-08 262614
SANDOZ TOBRAMYCIN 0.3% SOLUTION Resolved 2022-12-28 2023-03-06 179587
SANDOZ TOBRAMYCIN 0.3% SOLUTION Resolved 2023-11-06 2023-11-14 209227
SANDOZ TOBRAMYCIN 0.3% SOLUTION Resolved 2025-10-20 2025-10-27 269913
SANDOZ TOBRAMYCIN 0.3% SOLUTION Resolved 2023-07-17 2023-07-25 198853
SANDOZ TOBRAMYCIN 0.3% 0.3% SOLUTION Resolved 2017-05-15 2017-09-07 10336
SANDOZ TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2017-03-14 2017-04-11 2666
SANDOZ TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2024-05-21 2024-07-03 228430
SANDOZ TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Actual shortage 2025-05-26 2026-04-13 258273
SANDOZ TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2019-02-18 2019-04-17 76162
SANDOZ TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2017-03-14 2017-04-11 2663
SANDOZ TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2017-03-14 2017-04-18 2660
SANDOZ TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2018-04-03 2018-05-07 44813
SANDOZ TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2018-10-15 2018-11-04 64176
SANDOZ TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2021-02-01 2021-02-22 133037
SANDOZ TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2024-12-02 2024-12-24 244431
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136